Top compounds associated with response to SLC25A40


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA clofarabine CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA nelarabine CTRPv2 pan-cancer AAC 0.15 0.0003
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA BRD-K13999467 CTRPv2 pan-cancer AAC 0.14 0.0003
mRNA fingolimod CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA Topotecan CCLE pan-cancer AAC 0.16 0.0005
Download CSV